Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Daiichi claims LTD4 antagonists for treating allergic diseases

Dec. 12, 1996

HMR describes NK1/NK2 antagonists for respiratory indications

Dec. 11, 1996

Japanese researchers disclose substance P antagonists

Dec. 5, 1996

PDE IV inhibitors/cytokine inhibitors disclosed by Janssen

Dec. 4, 1996

Bronchoselective beta-adrenergic agonists reported by Almirall

Dec. 4, 1996

Pulmozyme cleared for advanced CF

Dec. 3, 1996

RPR claims dual-action TNF/cAMP phosphodiesterase inhibitors

Dec. 3, 1996

Dual-action PDE IV/TNF-alpha inhibitors reported by Janssen

Dec. 2, 1996

Canadian scientists identify new target for respiratory drugs

Nov. 28, 1996

PDE IV inhibitors reported by E. Merck

Nov. 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...